Search Results
Sep 09, 2026, 04:21 ET Qedma and HQC2 Demonstrate Unprecedented Accuracy in Quantum Chemistry on Quantum Computers
package, which enables the calculation of ground- and excited-state energies as well as molecular spectroscopic properties, including UV/Vis, CD and NMR spin-spin coupling constants, on quantum computing platforms.Qedma Media Contact:Diane McKayeSi14 Global Communications
More news about: Qedma
Sep 01, 2026, 08:45 ET Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Potency Assay
Boulet.NMR spectroscopy is additionally used as an orthogonal analytical characterization tool to assess the overall chemical reproducibility of the botanical extract providing an additional measure of the consistency achieved through Devonian's proprietary extraction process. To date, NMR analyses
More news about: Devonian Health Group Inc.
Aug 24, 2026, 08:30 ET Nanalysis Announces Second Quarter 2026 Results
FRA: 1N1), a leader in portable NMR spectrometers and imaging technology for government, industrial and research applications, announces its financial results for the second quarter ending
More news about: Nanalysis Scientific Corp.
Aug 19, 2026, 09:14 ET XtalPi Holdings Announces 2026 Interim Results
83% to 94%. The LCMS spectral analysis algorithm achieved an overall prediction accuracy of 95%, rising to 98% within the high-confidence range. The NMR spectral interpretation algorithm automatically analyzed more than 70% of spectra across four projects. At the Agentic System level, seven dedicated
More news about: XtalPi Holdings Limited
Aug 18, 2026, 08:30 ET Nanalysis Announces Second Quarter 2026 Conference Call
FRA: 1N1), a leader in benchtop NMR instruments and imaging technology and services for industrial and research applications announces that on Monday, August 24th 2026, the Company
More news about: Nanalysis Scientific Corp.
Jul 29, 2026, 17:00 ET AGNICO EAGLE REPORTS SECOND QUARTER 2026 RESULTS - RECORD QUARTERLY FREE CASH FLOW REFLECTS SOLID OPERATIONAL PERFORMANCE; RECORD QUARTERLY SHAREHOLDER RETURNS
lands), the Crown holds the subsurface mineral rights and imposes a net profits royalty (the "Crown royalty") under the Nunavut Mining Regulations (the "NMR"). The Company does not include the Crown royalty in its calculations of total cash costs per ounce and certain other of its non-GAAP measures as the
More news about: Agnico Eagle Mines Limited
Jul 07, 2026, 03:14 ET Kanazawa University research: Watching Molecules Change Shape in Slow Motion
forms. Because the switching process occurred slowly, the researchers were able to monitor the intermediate stages using nuclear magnetic resonance (NMR) and circular dichroism (CD) spectroscopy. X-ray crystallography and theoretical calculations were used to characterize the initial and final molecular
More news about: Kanazawa University
Jul 03, 2026, 08:00 ET Nanalysis Announces Grant of Options and Restricted Share Units
Scientific Corp. (TSXV: NSCI, FRA: 1N1) Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers used worldwide in pharma, biotech, energy, food, materials, and security industries, as well as in academic and government labs. The Company
More news about: Nanalysis Scientific Corp.
Jul 01, 2026, 08:34 ET Blood Test Screens Dogs for Multiple Diseases at Once, Peer-Reviewed Study Shows
LatusPet Limited, a University of Oxford biotech startup, today announced a first-of-its-kind scientific publication, titled "Application of NMR-Based Metabolomics and Machine Learning for Non-Invasive Disease Screening in Dogs," in
More news about: LatusPet Limited
Jun 23, 2026, 17:00 ET Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, Contract Wins and Corporate Activities
AB, June 23, 2026 Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and imaging technology for industrial and research applications, announces a series of strategic developments, including a quantum technology
More news about: Nanalysis Scientific Corp.
Jun 19, 2026, 08:22 ET Emilie Korchak Presented with a $20,000 Research Grant from Uplifting Athletes and the Foundation for Hao-Fountain Syndrome
UConn Health, where she studies how variants in the USP7 gene change the way the USP7 protein folds, functions, and binds to its partner proteins. Using NMR spectroscopy and biophysical binding assays, her work aims to explain why different USP7 variants lead to Hao-Fountain Syndrome, knowledge that is essential
More news about: Foundation for Hao-Fountain Syndrome
Jun 03, 2026, 08:00 ET Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics
The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer NEWCASTLE, United Kingdom, June 3, 2026 /PRNewswire/
More news about: Leica Biosystems
May 28, 2026, 08:30 ET Hongli Group Inc. Engages Battery Technology Expert Dr. Phillip A. Medina IV as Independent Technical Advisor for Energy Storage Initiatives
electrochemical analysis and materials characterization using scanning electron microscopy (SEM), atomic force microscopy (AFM), and nuclear magnetic resonance (NMR).After his time at IBM, Dr. Medina worked as the Chief Battery Scientist for an advanced battery technology developer, where he managed international
More news about: Hongli Group Inc.
May 27, 2026, 08:08 ET SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies
alpha-synuclein, tau, and A-beta. By integrating cutting-edge technologies like Cryo-EM electron diffraction, helical filament imaging, and In-cell NMR spectroscopy, we have built unparalleled expertise in key neurodegenerative disease targets, unlocking new possibilities for innovative therapeutic solutions
More news about: SynuSight Biotech
May 20, 2026, 16:51 ET Nanalysis Announces First Quarter 2026 Results
FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, announces its financial results for the first quarter ending March 31, 2026.
More news about: Nanalysis Scientific Corp.
May 19, 2026, 06:00 ET AGNICO EAGLE APPROVES HOPE BAY INVESTMENT DECISION; STRONG ECONOMIC RETURNS WITH EXPECTED ANNUAL GOLD PRODUCTION OF OVER 400,000 OUNCES
royalty regime in accordance with the Nunavut Mining Regulations ("NMR"). The royalty rate is based on a sliding scale to a maximum of 13%. The Doris deposit and Patch 7 zone are subject to a similar royalty payable to NTI ("NTI Payments"). The NMR royalties will be reflected in the income tax and effective
More news about: Agnico Eagle Mines Limited
May 14, 2026, 16:31 ET Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform
("LarmorBio") for LarmorBio's BioScan-NMR™ platform, a next-generation nuclear magnetic resonance (NMR) system. Under the agreement, Velocity Bioworks will host the first commercial deployment of the BioScan-NMR platform, with installation and commissioning at the Company's San Antonio facility targeted for
More news about: Valion Bio, Inc.
May 13, 2026, 16:15 ET Nanalysis Announces First Quarter 2026 Conference Call
FRA: 1N1), a leader in benchtop NMR instruments and imaging technology and services for industrial and research applications announces that on Wednesday, May 20th 2026, the Company
More news about: Nanalysis Scientific Corp.
May 12, 2026, 05:31 ET Scantox améliore DuplexSeq™ Bioinformatics avec une application de mutagenèse basée sur le cloud
recherche sous contrat (ORC) préclinique intégré qui accompagne les sponsors de la découverte au développement non clinique en vue d'obtenir l'homologation NMR (Nouveau Médicament de Recherche), avec des opérations au Danemark, en Suède, en Autriche et au Royaume-Uni. Nous combinons la découverte, la toxicologie
More news about: Scantox Group
May 01, 2026, 08:00 ET Nanalysis Announces Board Transition and Appointment of Three New Directors
FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications, is pleased to announce the appointment of Jonathan Ladd, Werner Maas, and
More news about: Nanalysis Scientific Corp.
Apr 30, 2026, 17:00 ET AGNICO EAGLE REPORTS FIRST QUARTER 2026 RESULTS, INCLUDING RECORD QUARTERLY OPERATING MARGINS AND ADJUSTED NET INCOME
lands), the Crown holds the subsurface mineral rights and imposes a net profits royalty (the "Crown royalty") under the Nunavut Mining Regulations (the "NMR"). The Company does not include the Crown royalty in its calculations of total cash costs per ounce and certain other of its non-GAAP measures as the
More news about: Agnico Eagle Mines Limited
Apr 14, 2026, 20:00 ET SST001, an α-syn PET tracer from Mabwell's incubated company SynuSight Biotech, received NMPA approval to initiate a clinical trial
alpha-synuclein, tau, and A-beta. By integrating cutting-edge technologies like Cryo-EM electron diffraction, helical filament imaging, and In-cell NMR spectroscopy, we have built unparalleled expertise in key neurodegenerative disease targets, unlocking new possibilities for innovative therapeutic solutions
More news about: Mabwell
Apr 10, 2026, 12:52 ET Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®
precision medicine, biomarker discovery, and systems biology research. Technological advancements in mass spectrometry and nuclear magnetic resonance (NMR), coupled with increasing pharmaceutical and biotechnology investments, are enabling high-throughput metabolite profiling. However, challenges such as
More news about: Verified Market Research
Apr 08, 2026, 16:15 ET Nanalysis Announces Fourth Quarter and Full Year 2025 Results
FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces its financial results for the fourth quarter and full year ended
More news about: Nanalysis Scientific Corp.
Apr 02, 2026, 08:00 ET Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call
FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications announces that on Wednesday, April 8th 2026, the
More news about: Nanalysis Scientific Corp.